Sutro Biopharma, Inc. (STRO)
NASDAQ: STRO · Real-Time Price · USD
0.8882
+0.0113 (1.29%)
At close: Sep 15, 2025, 4:00 PM EDT
0.9047
+0.0165 (1.86%)
After-hours: Sep 15, 2025, 6:38 PM EDT
Sutro Biopharma Market Cap
Sutro Biopharma has a market cap or net worth of $75.30 million as of September 15, 2025. Its market cap has decreased by -80.82% in one year.
Market Cap
75.30M
Enterprise Value
-110.24M
1-Year Change
-80.82%
Ranking
Category
Stock Price
$0.89
Market Cap Chart
Since September 27, 2018, Sutro Biopharma's market cap has decreased from $346.92M to $75.30M, a decrease of -78.30%. That is a compound annual growth rate of -19.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 74.34M | -51.00% |
| Dec 31, 2024 | 151.72M | -41.98% |
| Dec 29, 2023 | 261.49M | -43.69% |
| Dec 30, 2022 | 464.40M | -32.55% |
| Dec 31, 2021 | 688.50M | -30.31% |
| Dec 31, 2020 | 987.90M | 288.95% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |